Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis
For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, invest...
Saved in:
Published in | Archives of biochemistry and biophysics Vol. 745; p. 109716 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, investigating the molecular mechanism underlying HPV-induced cervical cancer has become a prominent research area. The HPV molecule is composed of a long control region (LCR), an early coding region and a late coding region.The early coding region encompasses E1, E2, E4, E5, E6, E7, while the late coding region comprises L1 and L2 ORF.The investigation into the molecular structure and function of HPV has garnered significant attention, with the aim of elucidating the carcinogenic mechanism of HPV and identifying potential targets for the treatment of cervical cancer. Research has demonstrated that the HPV gene and its encoded protein play a crucial role in the invasion and malignant transformation of host cells. Consequently, understanding the function of HPV oncoprotein is of paramount importance in comprehending the pathogenesis of cervical cancer. E6 and E7, the primary HPV oncogenic proteins, have been the subject of extensive study. Moreover, a number of contemporary investigations have demonstrated the significant involvement of HPV16 E5 oncoprotein in the malignant conversion of healthy cells through its regulation of cell proliferation, differentiation, and apoptosis via diverse pathways, albeit the precise molecular mechanism remains unclear. This manuscript aims to provide a comprehensive account of the molecular structure and life cycle of HPV.The HPV E5 oncoprotein mechanism modulates cellular processes such as proliferation, differentiation, apoptosis, and energy metabolism through its interaction with cell growth factor receptors and other cellular proteins. This mechanism is crucial for the survival, adhesion, migration, and invasion of tumor cells in the early stages of carcinogenesis. Recent studies have identified the HPV E5 oncoprotein as a promising therapeutic target for early-stage cervical cancer, thus offering a novel approach for treatment.
[Display omitted]
•HPV16 E5 oncoprotein plays an important role in tumor progression.•HPV16 E5 oncoprotein promotes tumor progression in several ways.•Potential therapeutic approaches targeting HPV16 E5 signaling pathway.•Therapies targeting HPV16 E5 oncoprotein. |
---|---|
AbstractList | For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, investigating the molecular mechanism underlying HPV-induced cervical cancer has become a prominent research area. The HPV molecule is composed of a long control region (LCR), an early coding region and a late coding region.The early coding region encompasses E1, E2, E4, E5, E6, E7, while the late coding region comprises L1 and L2 ORF.The investigation into the molecular structure and function of HPV has garnered significant attention, with the aim of elucidating the carcinogenic mechanism of HPV and identifying potential targets for the treatment of cervical cancer. Research has demonstrated that the HPV gene and its encoded protein play a crucial role in the invasion and malignant transformation of host cells. Consequently, understanding the function of HPV oncoprotein is of paramount importance in comprehending the pathogenesis of cervical cancer. E6 and E7, the primary HPV oncogenic proteins, have been the subject of extensive study. Moreover, a number of contemporary investigations have demonstrated the significant involvement of HPV16 E5 oncoprotein in the malignant conversion of healthy cells through its regulation of cell proliferation, differentiation, and apoptosis via diverse pathways, albeit the precise molecular mechanism remains unclear. This manuscript aims to provide a comprehensive account of the molecular structure and life cycle of HPV.The HPV E5 oncoprotein mechanism modulates cellular processes such as proliferation, differentiation, apoptosis, and energy metabolism through its interaction with cell growth factor receptors and other cellular proteins. This mechanism is crucial for the survival, adhesion, migration, and invasion of tumor cells in the early stages of carcinogenesis. Recent studies have identified the HPV E5 oncoprotein as a promising therapeutic target for early-stage cervical cancer, thus offering a novel approach for treatment. For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, investigating the molecular mechanism underlying HPV-induced cervical cancer has become a prominent research area. The HPV molecule is composed of a long control region (LCR), an early coding region and a late coding region.The early coding region encompasses E1, E2, E4, E5, E6, E7, while the late coding region comprises L1 and L2 ORF.The investigation into the molecular structure and function of HPV has garnered significant attention, with the aim of elucidating the carcinogenic mechanism of HPV and identifying potential targets for the treatment of cervical cancer. Research has demonstrated that the HPV gene and its encoded protein play a crucial role in the invasion and malignant transformation of host cells. Consequently, understanding the function of HPV oncoprotein is of paramount importance in comprehending the pathogenesis of cervical cancer. E6 and E7, the primary HPV oncogenic proteins, have been the subject of extensive study. Moreover, a number of contemporary investigations have demonstrated the significant involvement of HPV16 E5 oncoprotein in the malignant conversion of healthy cells through its regulation of cell proliferation, differentiation, and apoptosis via diverse pathways, albeit the precise molecular mechanism remains unclear. This manuscript aims to provide a comprehensive account of the molecular structure and life cycle of HPV.The HPV E5 oncoprotein mechanism modulates cellular processes such as proliferation, differentiation, apoptosis, and energy metabolism through its interaction with cell growth factor receptors and other cellular proteins. This mechanism is crucial for the survival, adhesion, migration, and invasion of tumor cells in the early stages of carcinogenesis. Recent studies have identified the HPV E5 oncoprotein as a promising therapeutic target for early-stage cervical cancer, thus offering a novel approach for treatment.For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, investigating the molecular mechanism underlying HPV-induced cervical cancer has become a prominent research area. The HPV molecule is composed of a long control region (LCR), an early coding region and a late coding region.The early coding region encompasses E1, E2, E4, E5, E6, E7, while the late coding region comprises L1 and L2 ORF.The investigation into the molecular structure and function of HPV has garnered significant attention, with the aim of elucidating the carcinogenic mechanism of HPV and identifying potential targets for the treatment of cervical cancer. Research has demonstrated that the HPV gene and its encoded protein play a crucial role in the invasion and malignant transformation of host cells. Consequently, understanding the function of HPV oncoprotein is of paramount importance in comprehending the pathogenesis of cervical cancer. E6 and E7, the primary HPV oncogenic proteins, have been the subject of extensive study. Moreover, a number of contemporary investigations have demonstrated the significant involvement of HPV16 E5 oncoprotein in the malignant conversion of healthy cells through its regulation of cell proliferation, differentiation, and apoptosis via diverse pathways, albeit the precise molecular mechanism remains unclear. This manuscript aims to provide a comprehensive account of the molecular structure and life cycle of HPV.The HPV E5 oncoprotein mechanism modulates cellular processes such as proliferation, differentiation, apoptosis, and energy metabolism through its interaction with cell growth factor receptors and other cellular proteins. This mechanism is crucial for the survival, adhesion, migration, and invasion of tumor cells in the early stages of carcinogenesis. Recent studies have identified the HPV E5 oncoprotein as a promising therapeutic target for early-stage cervical cancer, thus offering a novel approach for treatment. For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical cancer have garnered extensive attention, with prolonged chronic infection of HPV serving as a crucial etiological factor. Consequently, investigating the molecular mechanism underlying HPV-induced cervical cancer has become a prominent research area. The HPV molecule is composed of a long control region (LCR), an early coding region and a late coding region.The early coding region encompasses E1, E2, E4, E5, E6, E7, while the late coding region comprises L1 and L2 ORF.The investigation into the molecular structure and function of HPV has garnered significant attention, with the aim of elucidating the carcinogenic mechanism of HPV and identifying potential targets for the treatment of cervical cancer. Research has demonstrated that the HPV gene and its encoded protein play a crucial role in the invasion and malignant transformation of host cells. Consequently, understanding the function of HPV oncoprotein is of paramount importance in comprehending the pathogenesis of cervical cancer. E6 and E7, the primary HPV oncogenic proteins, have been the subject of extensive study. Moreover, a number of contemporary investigations have demonstrated the significant involvement of HPV16 E5 oncoprotein in the malignant conversion of healthy cells through its regulation of cell proliferation, differentiation, and apoptosis via diverse pathways, albeit the precise molecular mechanism remains unclear. This manuscript aims to provide a comprehensive account of the molecular structure and life cycle of HPV.The HPV E5 oncoprotein mechanism modulates cellular processes such as proliferation, differentiation, apoptosis, and energy metabolism through its interaction with cell growth factor receptors and other cellular proteins. This mechanism is crucial for the survival, adhesion, migration, and invasion of tumor cells in the early stages of carcinogenesis. Recent studies have identified the HPV E5 oncoprotein as a promising therapeutic target for early-stage cervical cancer, thus offering a novel approach for treatment. [Display omitted] •HPV16 E5 oncoprotein plays an important role in tumor progression.•HPV16 E5 oncoprotein promotes tumor progression in several ways.•Potential therapeutic approaches targeting HPV16 E5 signaling pathway.•Therapies targeting HPV16 E5 oncoprotein. |
ArticleNumber | 109716 |
Author | Zhao, Liping Chen, Biqing Xu, Tianmin Yang, Rulin |
Author_xml | – sequence: 1 givenname: Biqing surname: Chen fullname: Chen, Biqing – sequence: 2 givenname: Liping surname: Zhao fullname: Zhao, Liping – sequence: 3 givenname: Rulin surname: Yang fullname: Yang, Rulin – sequence: 4 givenname: Tianmin surname: Xu fullname: Xu, Tianmin email: xutianmin@126.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37553047$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1r3DAQhkXYkOxu8wN6KT724q3GkiWbnpaQZAOB5tD2KvQxTrXYUip5A_33Vdikhx5CTpqB5x3E-6zIIsSAhHwEugEK4st-o43ZNLRhZe8liBOyLIOoKev4giwppazuOwHnZJXznlIALpozcs5k2zLK5ZJcb92TDhZz5UM1xRHtYdSpmtD-0sHnqYpDtbv_CaK6aqsYbHxMccbCWp2sD_EBA2afP5DTQY8ZL17eNflxffX9clfffbu5vdze1ZZ1Yq67FpA53vZGSGi506I3zA7gUGgBIAbuTAMNL4thgwDJpROmN9IZ3ToAtiafj3fLN34fMM9q8tniOOqA8ZBV03VSMNbT96C8axilpYk1-fSCHsyETj0mP-n0R73WVAA4AjbFnBMO_xCg6lmF2quiQj2rUEcVJSP_y1g_69nHMCftxzeTX49JLE0-eUwqW49FkvMJ7axc9G-k_wLNB6AZ |
CitedBy_id | crossref_primary_10_1186_s13027_024_00581_8 crossref_primary_10_3892_etm_2024_12671 crossref_primary_10_3390_ijms25147616 crossref_primary_10_2147_OTT_S475132 crossref_primary_10_1016_j_tvr_2025_200315 crossref_primary_10_1016_j_tvr_2024_200311 crossref_primary_10_4103_tcmj_tcmj_134_24 crossref_primary_10_3389_fonc_2024_1488730 crossref_primary_10_3390_v16030416 |
Cites_doi | 10.1006/viro.1996.0475 10.1016/j.virol.2018.03.021 10.1016/S1046-5928(03)00049-4 10.1158/1541-7786.MCR-20-0491 10.1007/s10555-012-9375-7 10.1016/j.virol.2010.01.009 10.1101/gr.082701.108 10.18632/oncotarget.3326 10.15430/JCP.2013.18.2.123 10.1038/emboj.2008.172 10.1159/000076642 10.2174/1389202915666140528003249 10.1128/JVI.00706-11 10.1016/j.tvr.2023.200258 10.1128/JVI.06243-11 10.1158/1078-0432.CCR-17-1438 10.1093/jnci/djn025 10.1038/s41388-017-0045-7 10.3390/v7102880 10.1016/j.ygyno.2006.03.036 10.1042/CS20160786 10.1128/JVI.01003-09 10.1016/j.ygyno.2010.01.024 10.1128/JVI.78.3.1333-1343.2004 10.1002/rmv.1822 10.1016/j.antiviral.2018.08.005 10.1093/carcin/bgn236 10.1128/jvi.67.8.4521-4532.1993 10.1093/carcin/bgp318 10.1128/JVI.76.23.12162-12172.2002 10.1097/CEJ.0000000000000023 10.1016/j.bpobgyn.2017.08.006 10.1128/jvi.70.11.7535-7539.1996 10.1016/j.virusres.2016.11.010 10.3390/ijms19071839 10.1002/ijc.22089 10.1128/JVI.00458-19 10.1016/j.virol.2013.06.006 10.1007/s00705-014-2305-y 10.1016/S1570-9639(02)00408-9 10.2217/fvl.10.73 10.1084/jem.20071311 10.1128/JVI.01582-19 10.1097/LGT.0000000000000104 10.1099/jgv.0.001540 10.3892/ol.2015.3580 10.1038/sj.onc.1208453 10.1038/sj.onc.1210916 10.1038/srep07653 10.1093/carcin/bgp250 10.1093/femspd/ftz048 10.1099/vir.0.000201 10.1158/0008-5472.CAN-09-3436 10.1002/j.1460-2075.1994.tb06880.x 10.1042/bj3130051 10.1016/j.ccr.2005.04.014 10.1073/pnas.1416074111 10.1016/j.virol.2008.10.011 10.1007/978-3-642-38965-8_8 10.3390/ijms22179657 10.1186/s13027-016-0107-4 10.1128/JVI.76.1.220-231.2002 10.1186/s13046-017-0541-1 10.1016/j.cell.2011.07.030 10.1158/0008-5472.CAN-05-0083 10.1016/j.bbrc.2010.07.125 10.1590/0074-02760190405 10.1016/j.bbrc.2008.04.122 10.1093/nar/21.25.5817 10.1007/s00018-005-5561-x 10.1016/j.virol.2010.06.025 10.1016/j.cell.2009.01.002 10.1002/ijc.29373 10.1038/nrc2886 10.1371/journal.ppat.1002657 10.4103/0971-5851.195751 10.1371/journal.ppat.1003237 10.1016/j.micpath.2019.103923 10.1093/infdis/jir341 10.1016/j.ajog.2014.06.059 10.1016/j.cub.2007.01.049 10.2217/fmb.10.107 10.1128/JVI.00831-10 10.1093/carcin/bgp281 10.1186/s12943-015-0361-x 10.1371/journal.pone.0021646 10.1161/01.HYP.0000142232.29764.a7 10.1021/acs.jpcb.6b10050 10.1128/JVI.01240-08 10.1016/j.virol.2014.04.024 10.1002/path.3997 10.1016/j.virol.2013.07.020 10.1155/2014/748740 10.1177/1745506520961709 10.1001/jamaoncol.2016.5688 10.1155/2018/5315816 10.1006/abbi.1993.1197 10.1016/j.virol.2013.07.008 10.1038/sj.onc.1209768 10.1158/0008-5472.CAN-06-4273 10.1128/jvi.69.7.4489-4494.1995 10.1186/s13027-023-00488-w 10.3892/ol.2014.2417 10.1007/s00404-020-05559-6 10.1242/dev.091744 10.3390/v9090245 10.5455/medarh.2018.72.26-30 10.1093/carcin/bgp066 10.1093/annonc/mdl347 10.1080/21645515.2017.1264777 10.1186/1476-4598-12-38 10.1016/j.cell.2007.12.018 10.1186/1475-2867-6-19 10.1016/j.virol.2014.01.013 10.1007/s10156-012-0485-5 |
ContentType | Journal Article |
Copyright | 2023 Elsevier Inc. Copyright © 2023 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier Inc. – notice: Copyright © 2023 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.abb.2023.109716 |
DatabaseName | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1096-0384 |
ExternalDocumentID | 37553047 10_1016_j_abb_2023_109716 S0003986123002151 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M -DZ -~X .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFRF ABGSF ABJNI ABMAC ABPPZ ABUDA ABYKQ ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DM4 DOVZS EBS EFBJH EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HLW IH2 IHE J1W KOM L7B LG5 LX2 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RNS ROL RPZ SDF SDG SDP SES SEW SPCBC SSU SSZ T5K TWZ WH7 ~02 ~G- .55 .GJ .HR 3O- 53G AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABEFU ABFNM ABWVN ABXDB ACRPL ACVFH ADCNI ADFGL ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGHFR AGQPQ AGRDE AGRNS AHHHB AI. AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF EJD FEDTE FGOYB G-2 HVGLF HZ~ K-O MVM NEJ OHT R2- RIG SBG SSH UQL VH1 WUQ X7M XOL XPP YYP ZGI ZMT ZXP ~KM NPM 7X8 7S9 EFKBS L.6 |
ID | FETCH-LOGICAL-c386t-851e3d459b67154da69b3cf1de6a6116f4db2124a61b3f61747d6b9b7dba5d113 |
IEDL.DBID | .~1 |
ISSN | 0003-9861 1096-0384 |
IngestDate | Fri Aug 22 20:27:30 EDT 2025 Fri Jul 11 00:29:23 EDT 2025 Thu Apr 03 07:06:22 EDT 2025 Tue Jul 01 01:32:08 EDT 2025 Thu Apr 24 23:01:00 EDT 2025 Fri Feb 23 02:35:47 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | E5 oncoprotein Growth factors Cell apoptosis HPV16 |
Language | English |
License | Copyright © 2023 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c386t-851e3d459b67154da69b3cf1de6a6116f4db2124a61b3f61747d6b9b7dba5d113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 37553047 |
PQID | 2848230055 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2887633901 proquest_miscellaneous_2848230055 pubmed_primary_37553047 crossref_primary_10_1016_j_abb_2023_109716 crossref_citationtrail_10_1016_j_abb_2023_109716 elsevier_sciencedirect_doi_10_1016_j_abb_2023_109716 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-09-01 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Archives of biochemistry and biophysics |
PublicationTitleAlternate | Arch Biochem Biophys |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Global Burden of Disease Cancer, Fitzmaurice, Allen, Barber, Barregard, Bhutta (bib1) 2017; 3 Graham (bib25) 2017; 131 de Freitas, de Oliveira, Barros, Venuti (bib125) 2017; 36 Pedroza-Saavedra, Lam, Esquivel-Guadarrama, Gutierrez-Xicotencatl (bib51) 2010; 400 Hariri, Unger, Sternberg, Dunne, Swan, Patel (bib6) 2011; 204 Rubinsztein, Marino, Kroemer (bib90) 2011; 146 Sofiani, Veisi, Rukerd, Ghazi, Nakhaie (bib30) 2023; 18 Suprynowicz, Krawczyk, Hebert, Sudarshan, Simic, Kamonjoh (bib49) 2010; 84 Graham (bib31) 2017; 9 Scott, Woodby, Ulicny, Raikhy, Orr, Songock (bib56) 2020; 94 Krawczyk, Suprynowicz, Hebert, Kamonjoh, Schlegel (bib87) 2011; 85 Lazarczyk, Pons, Mendoza, Cassonnet, Jacob, Favre (bib39) 2008; 205 Hu, Potapova, Li, Rankin, Gorbsky, Angeletti (bib65) 2010; 405 Hughes, Romanos (bib15) 1993; 21 Biktasova, Hajek, Sewell, Gary, Bellinger, Deshpande (bib117) 2017; 23 Ye, Wang, Jeschke, von Schonfeldt (bib98) 2020; 301 Maufort, Shai, Pitot, Lambert (bib21) 2010; 70 Belleudi, Nanni, Raffa, Torrisi (bib93) 2015; 6 Gutierrez-Xicotencatl, Pedroza-Saavedra, Chihu-Amparan, Salazar-Pina, Maldonado-Gama, Esquivel-Guadarrama (bib108) 2021; 19 Kim, Oh, No, Bang, Juhnn, Song (bib115) 2009; 30 Wetherill, Wasson, Swinscoe, Kealy, Foster, Griffin (bib41) 2018; 158 Mighty, Laimins (bib19) 2014; 193 Wetherill, Holmes, Verow, Muller, Howell, Harris (bib42) 2012; 86 Sudarshan, Schlegel, Liu (bib76) 2010; 399 Stanley (bib7) 2010; 117 Bakhtiyrizadeh, Hosseini, Yaghobi, Safaei, Sarvari (bib2) 2017; 18 Stoppler, Straight, Tsao, Schlegel, McCance (bib72) 1996; 223 Aleksioska-Papestiev, Chibisheva, Micevska, Dimitrov (bib5) 2018; 72 Alonso, Reed (bib43) 2002; 1601 Lim, Kaldis (bib104) 2013; 140 Paolini, Curzio, Cordeiro, Massa, Mariani, Pimpinelli (bib124) 2017; 13 Bartel (bib79) 2009; 136 Nelson, Mirabello (bib35) 2023; 15 Royle, Dobson, Muller, Macdonald (bib63) 2015; 7 Schelhaas, Shah, Holzer, Blattmann, Kuhling, Day (bib23) 2012; 8 Martinez-Ramirez, Carrillo-Garcia, Contreras-Paredes, Ortiz-Sanchez, Cruz-Gregorio, Lizano (bib94) 2018; 19 Zhang, Wu, Ling, Zhao, Zhao (bib12) 2015; 14 Scott, Coleman, Kelly, Carroll, Woodby, Songock (bib59) 2018; 519 Hu, Potapova, Li, Rankin, Gorbsky, Angeletti (bib89) 2010; 405 Wang, Yang, Huang, Huang, Gao, Zhao (bib92) 2014; 8 Gutierrez-Xicotencatl, Pedroza-Saavedra, Chihu-Amparan, Salazar-Pina, Maldonado-Gama, Esquivel-Guadarrama (bib44) 2021; 19 Puisieux, Ji, Ozturk (bib88) 1996; 313 Doorbar (bib17) 2013; 445 Oelze, Kartenbeck, Crusius, Alonso (bib73) 1995; 69 Farley, Truong, Goo, Uyehara, Belnap, Larsen (bib120) 2006; 103 Scott, Griffin (bib130) 2015; 96 Subbaramaiah, Dannenberg (bib110) 2007; 67 de Freitas, de Oliveira, Barros, Venuti (bib20) 2017; 36 Doorbar, Egawa, Griffin, Kranjec, Murakami (bib22) 2015; 25 Greco, Kivi, Qian, Leivonen, Auvinen, Auvinen (bib80) 2011; 6 An, Aksoy, Zheng, Fan, Weiss (bib96) 2018; 37 Wetherill, Holmes, Verow, Muller, Howell, Harris (bib131) 2012; 86 Raikhy, Woodby, Scott, Shin, Myers, Scott (bib55) 2019; 93 Straight, Hinkle, Jewers, McCance (bib95) 1993; 67 Royle, Dobson, Muller, Macdonald (bib129) 2015; 7 Oh, Kim, Lee, Seo, Kim, Song (bib111) 2009; 30 Soriano-Hernandez, Madrigal-Perez, Galvan-Salazar, Martinez-Fierro, Valdez-Velazquez, Espinoza-Gomez (bib119) 2015; 10 Yang, Wildeman, Sharom (bib36) 2003; 30 Williams, Filippova, Soto, Duerksen-Hughes (bib14) 2011; 6 Oliva, Wu, Yang (bib62) 1993; 302 Sasagawa, Takagi, Makinoda (bib112) 2012; 18 Furuta, Kozaki, Tanaka, Arii, Imoto, Inazawa (bib81) 2010; 31 Schiffman, Doorbar, Wentzensen, de Sanjose, Fakhry, Monk (bib86) 2016; 2 Kabsch, Mossadegh, Kohl, Komposch, Schenkel, Alonso (bib68) 2004; 47 Parida, Mandal (bib109) 2014; 23 Hochmann, Parietti, Martinez, Lopez, Carreno, Quijano (bib99) 2020; 115 Kim, Juhnn, Kang, Park, Sung, Bang (bib52) 2006; 63 Ashrafi, Haghshenas, Marchetti, Campo (bib40) 2006; 119 Boulenouar, Weyn, Van Noppen, Moussa Ali, Favre, Delvenne (bib60) 2010; 31 DiGiuseppe, Bienkowska-Haba, Hilbig, Sapp (bib24) 2014; 458–459 Strohl, Mendoza, Ghant, Cameron, Simon, Schink (bib3) 2015; 212 Senapati, Senapati, Dwibedi (bib29) 2016; 11 Gillison, D'Souza, Westra, Sugar, Xiao, Begum (bib8) 2008; 100 Kivi, Greco, Auvinen, Auvinen (bib70) 2008; 27 Bouvard, Storey, Pim, Banks (bib16) 1994; 13 French, Belleudi, Mauro, Mazzetta, Raffa, Fabiano (bib58) 2013; 12 Parfenov, Pedamallu, Gehlenborg, Freeman, Danilova, Bristow (bib10) 2014; 111 Spangle, Munger (bib103) 2013; 9 Hu, Plafker, Vorozhko, Zuna, Hanigan, Gorbsky (bib84) 2009; 384 Hemmat, Bannazadeh Baghi (bib107) 2019; 77 Crusz, El-Shakankery, Miller (bib126) 2020; 16 Regan, Laimins (bib38) 2008; 82 Shi, Du, Liu, Qian, Hu, Yu (bib122) 2012; 228 Mahato, Fischer (bib128) 2016; 120 Cerqueira, Schiller (bib28) 2017; 231 Liu, Lin, Li, Zhang, Chen, Cao (bib83) 2015; 5 McBride (bib27) 2013; 445 Zhang, Spandau, Roman (bib67) 2002; 76 Liu, Li, Pi, Yang, Zhao, Qi (bib127) 2019; 55 Scott, Coleman, Kelly, Carroll, Woodby, Songock (bib48) 2018; 519 Drabsch, ten Dijke (bib57) 2012; 31 Serrano, Brotons, Bosch, Bruni (bib4) 2018; 47 Ilahi, Bhatti (bib34) 2020; 139 Kim, Kim, Kim, Suh, Chung, Song (bib116) 2013; 18 Ferretti, De Smaele, Miele, Laneve, Po, Pelloni (bib82) 2008; 27 Georgescu, Mitran, Mitran, Caruntu, Sarbu, Matei (bib97) 2018; 2018 Scarth, Patterson, Morgan, Macdonald (bib102) 2021; 102 Graham (bib18) 2010; 5 Nath, Mant, Kell, Cason, Bible (bib13) 2006; 6 Straight, Hinkle, Jewers, McCance (bib71) 1993; 67 Friel, Liu, Kolomeyevskaya, Hampras, Kruszka, Schmitt (bib118) 2015; 19 Chen, Lin, Tsao, Chen (bib123) 2004; 78 Grunberg (bib121) 2007; 18 Tsao, Li, Tsai, Chen (bib74) 1996; 70 Straight, Hinkle, Jewers, McCance (bib113) 1993; 67 de Visser, Korets, Coussens (bib114) 2005; 7 Wassmann, Wassmann, Nickenig (bib100) 2004; 44 Ranieri, Belleudi, Magenta, Torrisi (bib53) 2015; 137 Chen, Utro, Platt, DeSalle, Parida, Chan (bib33) 2021; 22 Moody, Laimins (bib11) 2010; 10 Krawczyk, Hanover, Schlegel, Suprynowicz (bib37) 2008; 371 Bobdey, Sathwara, Jain, Balasubramaniam (bib9) 2016; 37 Condjella, Liu, Suprynowicz, Yuan, Sudarshan, Dai (bib75) 2009; 83 Scott, Coleman, Kelly, Carroll, Woodby, Songock (bib54) 2018; 519 Levine, Kroemer (bib91) 2008; 132 Kabsch, Alonso (bib69) 2002; 76 Wetherill, Wasson, Swinscoe, Kealy, Foster, Griffin (bib64) 2018; 158 Adefuye, Katz, Sales (bib106) 2014; 2014 Genther Williams, Disbrow, Schlegel, Lee, Threadgill, Lambert (bib46) 2005; 65 Kotnik Halavaty, Regan, Mehta, Laimins (bib61) 2014; 452–453 Oh, Kim, Cho, Song, Kim, Juhnn (bib66) 2010; 31 Sharma, Dua, Agarwal (bib78) 2014; 15 Oh, Kim, Cho, Song, Kim, Juhnn (bib101) 2010; 31 Wetherill, Wasson, Swinscoe, Kealy, Foster, Griffin (bib132) 2018; 158 Bergvall, Melendy, Archambault (bib26) 2013; 445 Gutierrez-Xicotencatl, Pedroza-Saavedra, Chihu-Amparan, Salazar-Pina, Maldonado-Gama, Esquivel-Guadarrama (bib45) 2021; 19 Tsao, Li, Tsai, Chen (bib105) 1996; 70 Friedman, Farh, Burge, Bartel (bib77) 2009; 19 Zhang, Srirangam, Potter, Roman (bib50) 2005; 24 Gyongyosi, Szalmas, Ferenczi, Poliska, Konya, Veress (bib32) 2015; 160 Chen, Lin, Tsai, Hsiao, Tsao (bib47) 2007; 26 Duelli, Padilla-Nash, Berman, Murphy, Ried, Lazebnik (bib85) 2007; 17 Liu (10.1016/j.abb.2023.109716_bib83) 2015; 5 Wetherill (10.1016/j.abb.2023.109716_bib132) 2018; 158 Cerqueira (10.1016/j.abb.2023.109716_bib28) 2017; 231 Duelli (10.1016/j.abb.2023.109716_bib85) 2007; 17 Puisieux (10.1016/j.abb.2023.109716_bib88) 1996; 313 Grunberg (10.1016/j.abb.2023.109716_bib121) 2007; 18 Biktasova (10.1016/j.abb.2023.109716_bib117) 2017; 23 Greco (10.1016/j.abb.2023.109716_bib80) 2011; 6 Aleksioska-Papestiev (10.1016/j.abb.2023.109716_bib5) 2018; 72 Wetherill (10.1016/j.abb.2023.109716_bib131) 2012; 86 Lazarczyk (10.1016/j.abb.2023.109716_bib39) 2008; 205 Williams (10.1016/j.abb.2023.109716_bib14) 2011; 6 Bouvard (10.1016/j.abb.2023.109716_bib16) 1994; 13 Friedman (10.1016/j.abb.2023.109716_bib77) 2009; 19 Bergvall (10.1016/j.abb.2023.109716_bib26) 2013; 445 Graham (10.1016/j.abb.2023.109716_bib31) 2017; 9 Hu (10.1016/j.abb.2023.109716_bib89) 2010; 405 Oliva (10.1016/j.abb.2023.109716_bib62) 1993; 302 Royle (10.1016/j.abb.2023.109716_bib63) 2015; 7 Parida (10.1016/j.abb.2023.109716_bib109) 2014; 23 Mighty (10.1016/j.abb.2023.109716_bib19) 2014; 193 Spangle (10.1016/j.abb.2023.109716_bib103) 2013; 9 Hughes (10.1016/j.abb.2023.109716_bib15) 1993; 21 Tsao (10.1016/j.abb.2023.109716_bib74) 1996; 70 Moody (10.1016/j.abb.2023.109716_bib11) 2010; 10 Scarth (10.1016/j.abb.2023.109716_bib102) 2021; 102 Graham (10.1016/j.abb.2023.109716_bib25) 2017; 131 Drabsch (10.1016/j.abb.2023.109716_bib57) 2012; 31 Sudarshan (10.1016/j.abb.2023.109716_bib76) 2010; 399 Gyongyosi (10.1016/j.abb.2023.109716_bib32) 2015; 160 Liu (10.1016/j.abb.2023.109716_bib127) 2019; 55 Maufort (10.1016/j.abb.2023.109716_bib21) 2010; 70 Scott (10.1016/j.abb.2023.109716_bib59) 2018; 519 Schelhaas (10.1016/j.abb.2023.109716_bib23) 2012; 8 Nath (10.1016/j.abb.2023.109716_bib13) 2006; 6 Boulenouar (10.1016/j.abb.2023.109716_bib60) 2010; 31 Wetherill (10.1016/j.abb.2023.109716_bib41) 2018; 158 Martinez-Ramirez (10.1016/j.abb.2023.109716_bib94) 2018; 19 Tsao (10.1016/j.abb.2023.109716_bib105) 1996; 70 Chen (10.1016/j.abb.2023.109716_bib33) 2021; 22 Chen (10.1016/j.abb.2023.109716_bib47) 2007; 26 Yang (10.1016/j.abb.2023.109716_bib36) 2003; 30 Wetherill (10.1016/j.abb.2023.109716_bib64) 2018; 158 Gutierrez-Xicotencatl (10.1016/j.abb.2023.109716_bib108) 2021; 19 Wassmann (10.1016/j.abb.2023.109716_bib100) 2004; 44 Kabsch (10.1016/j.abb.2023.109716_bib69) 2002; 76 Oh (10.1016/j.abb.2023.109716_bib101) 2010; 31 Hariri (10.1016/j.abb.2023.109716_bib6) 2011; 204 Kivi (10.1016/j.abb.2023.109716_bib70) 2008; 27 Parfenov (10.1016/j.abb.2023.109716_bib10) 2014; 111 Chen (10.1016/j.abb.2023.109716_bib123) 2004; 78 Bobdey (10.1016/j.abb.2023.109716_bib9) 2016; 37 Wetherill (10.1016/j.abb.2023.109716_bib42) 2012; 86 de Visser (10.1016/j.abb.2023.109716_bib114) 2005; 7 Scott (10.1016/j.abb.2023.109716_bib56) 2020; 94 Gillison (10.1016/j.abb.2023.109716_bib8) 2008; 100 Pedroza-Saavedra (10.1016/j.abb.2023.109716_bib51) 2010; 400 Schiffman (10.1016/j.abb.2023.109716_bib86) 2016; 2 Ilahi (10.1016/j.abb.2023.109716_bib34) 2020; 139 Kim (10.1016/j.abb.2023.109716_bib115) 2009; 30 Zhang (10.1016/j.abb.2023.109716_bib12) 2015; 14 Hochmann (10.1016/j.abb.2023.109716_bib99) 2020; 115 Shi (10.1016/j.abb.2023.109716_bib122) 2012; 228 Belleudi (10.1016/j.abb.2023.109716_bib93) 2015; 6 Kabsch (10.1016/j.abb.2023.109716_bib68) 2004; 47 Genther Williams (10.1016/j.abb.2023.109716_bib46) 2005; 65 An (10.1016/j.abb.2023.109716_bib96) 2018; 37 McBride (10.1016/j.abb.2023.109716_bib27) 2013; 445 Oelze (10.1016/j.abb.2023.109716_bib73) 1995; 69 Condjella (10.1016/j.abb.2023.109716_bib75) 2009; 83 de Freitas (10.1016/j.abb.2023.109716_bib125) 2017; 36 Adefuye (10.1016/j.abb.2023.109716_bib106) 2014; 2014 Zhang (10.1016/j.abb.2023.109716_bib67) 2002; 76 Subbaramaiah (10.1016/j.abb.2023.109716_bib110) 2007; 67 Georgescu (10.1016/j.abb.2023.109716_bib97) 2018; 2018 Ranieri (10.1016/j.abb.2023.109716_bib53) 2015; 137 Oh (10.1016/j.abb.2023.109716_bib111) 2009; 30 de Freitas (10.1016/j.abb.2023.109716_bib20) 2017; 36 Zhang (10.1016/j.abb.2023.109716_bib50) 2005; 24 Lim (10.1016/j.abb.2023.109716_bib104) 2013; 140 Senapati (10.1016/j.abb.2023.109716_bib29) 2016; 11 Ferretti (10.1016/j.abb.2023.109716_bib82) 2008; 27 Soriano-Hernandez (10.1016/j.abb.2023.109716_bib119) 2015; 10 Rubinsztein (10.1016/j.abb.2023.109716_bib90) 2011; 146 Krawczyk (10.1016/j.abb.2023.109716_bib87) 2011; 85 Ye (10.1016/j.abb.2023.109716_bib98) 2020; 301 Gutierrez-Xicotencatl (10.1016/j.abb.2023.109716_bib45) 2021; 19 Straight (10.1016/j.abb.2023.109716_bib113) 1993; 67 Royle (10.1016/j.abb.2023.109716_bib129) 2015; 7 Krawczyk (10.1016/j.abb.2023.109716_bib37) 2008; 371 Oh (10.1016/j.abb.2023.109716_bib66) 2010; 31 Levine (10.1016/j.abb.2023.109716_bib91) 2008; 132 Mahato (10.1016/j.abb.2023.109716_bib128) 2016; 120 Stanley (10.1016/j.abb.2023.109716_bib7) 2010; 117 Straight (10.1016/j.abb.2023.109716_bib71) 1993; 67 Ashrafi (10.1016/j.abb.2023.109716_bib40) 2006; 119 Furuta (10.1016/j.abb.2023.109716_bib81) 2010; 31 Farley (10.1016/j.abb.2023.109716_bib120) 2006; 103 Serrano (10.1016/j.abb.2023.109716_bib4) 2018; 47 Sasagawa (10.1016/j.abb.2023.109716_bib112) 2012; 18 Strohl (10.1016/j.abb.2023.109716_bib3) 2015; 212 Stoppler (10.1016/j.abb.2023.109716_bib72) 1996; 223 Crusz (10.1016/j.abb.2023.109716_bib126) 2020; 16 Paolini (10.1016/j.abb.2023.109716_bib124) 2017; 13 Friel (10.1016/j.abb.2023.109716_bib118) 2015; 19 Kotnik Halavaty (10.1016/j.abb.2023.109716_bib61) 2014; 452–453 Gutierrez-Xicotencatl (10.1016/j.abb.2023.109716_bib44) 2021; 19 Suprynowicz (10.1016/j.abb.2023.109716_bib49) 2010; 84 Bartel (10.1016/j.abb.2023.109716_bib79) 2009; 136 Hu (10.1016/j.abb.2023.109716_bib84) 2009; 384 Scott (10.1016/j.abb.2023.109716_bib48) 2018; 519 Bakhtiyrizadeh (10.1016/j.abb.2023.109716_bib2) 2017; 18 French (10.1016/j.abb.2023.109716_bib58) 2013; 12 Raikhy (10.1016/j.abb.2023.109716_bib55) 2019; 93 Kim (10.1016/j.abb.2023.109716_bib52) 2006; 63 Regan (10.1016/j.abb.2023.109716_bib38) 2008; 82 Wang (10.1016/j.abb.2023.109716_bib92) 2014; 8 Scott (10.1016/j.abb.2023.109716_bib130) 2015; 96 Doorbar (10.1016/j.abb.2023.109716_bib17) 2013; 445 Hemmat (10.1016/j.abb.2023.109716_bib107) 2019; 77 Graham (10.1016/j.abb.2023.109716_bib18) 2010; 5 Scott (10.1016/j.abb.2023.109716_bib54) 2018; 519 Global Burden of Disease Cancer (10.1016/j.abb.2023.109716_bib1) 2017; 3 Hu (10.1016/j.abb.2023.109716_bib65) 2010; 405 Sofiani (10.1016/j.abb.2023.109716_bib30) 2023; 18 Nelson (10.1016/j.abb.2023.109716_bib35) 2023; 15 Sharma (10.1016/j.abb.2023.109716_bib78) 2014; 15 DiGiuseppe (10.1016/j.abb.2023.109716_bib24) 2014; 458–459 Doorbar (10.1016/j.abb.2023.109716_bib22) 2015; 25 Kim (10.1016/j.abb.2023.109716_bib116) 2013; 18 Alonso (10.1016/j.abb.2023.109716_bib43) 2002; 1601 Straight (10.1016/j.abb.2023.109716_bib95) 1993; 67 |
References_xml | – volume: 18 start-page: 13 year: 2023 ident: bib30 article-title: The complexity of human papilloma virus in cancers: a narrative review publication-title: Infect. Agents Cancer – volume: 115 year: 2020 ident: bib99 article-title: Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state publication-title: Mem. Inst. Oswaldo Cruz – volume: 117 start-page: S5 year: 2010 end-page: S10 ident: bib7 article-title: Pathology and epidemiology of HPV infection in females publication-title: Gynecol. Oncol. – volume: 8 year: 2012 ident: bib23 article-title: Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis publication-title: PLoS Pathog. – volume: 70 start-page: 2924 year: 2010 end-page: 2931 ident: bib21 article-title: A role for HPV16 E5 in cervical carcinogenesis publication-title: Cancer Res. – volume: 193 start-page: 135 year: 2014 end-page: 148 ident: bib19 article-title: The role of human papillomaviruses in oncogenesis publication-title: Recent Results Cancer Res. – volume: 31 start-page: 402 year: 2010 end-page: 410 ident: bib101 article-title: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells publication-title: Carcinogenesis – volume: 14 start-page: 87 year: 2015 ident: bib12 article-title: The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses publication-title: Mol. Cancer – volume: 18 start-page: 3319 year: 2017 end-page: 3324 ident: bib2 article-title: Almost complete lack of human cytomegalovirus and human papillomaviruses genome in benign and malignant breast lesions in shiraz, southwest of Iran publication-title: Asian Pac. J. Cancer Prev. APJCP – volume: 86 start-page: 5341 year: 2012 end-page: 5351 ident: bib42 article-title: High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors publication-title: J. Virol. – volume: 131 start-page: 2201 year: 2017 end-page: 2221 ident: bib25 article-title: The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review publication-title: Clin. Sci. (Lond.) – volume: 452–453 start-page: 223 year: 2014 end-page: 230 ident: bib61 article-title: Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation publication-title: Virology – volume: 132 start-page: 27 year: 2008 end-page: 42 ident: bib91 article-title: Autophagy in the pathogenesis of disease publication-title: Cell – volume: 31 start-page: 473 year: 2010 end-page: 480 ident: bib60 article-title: Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells publication-title: Carcinogenesis – volume: 100 start-page: 407 year: 2008 end-page: 420 ident: bib8 article-title: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers publication-title: J. Natl. Cancer Inst. – volume: 19 start-page: 167 year: 2021 end-page: 179 ident: bib45 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. – volume: 9 year: 2013 ident: bib103 article-title: The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species publication-title: PLoS Pathog. – volume: 22 year: 2021 ident: bib33 article-title: K-mer analyses reveal different evolutionary histories of alpha, beta, and gamma papillomaviruses publication-title: Int. J. Mol. Sci. – volume: 11 start-page: 59 year: 2016 ident: bib29 article-title: Molecular mechanisms of HPV mediated neoplastic progression publication-title: Infect. Agents Cancer – volume: 102 year: 2021 ident: bib102 article-title: The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation publication-title: J. Gen. Virol. – volume: 31 start-page: 402 year: 2010 end-page: 410 ident: bib66 article-title: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells publication-title: Carcinogenesis – volume: 82 start-page: 10042 year: 2008 end-page: 10051 ident: bib38 article-title: Bap31 is a novel target of the human papillomavirus E5 protein publication-title: J. Virol. – volume: 85 start-page: 10968 year: 2011 end-page: 10975 ident: bib87 article-title: The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region publication-title: J. Virol. – volume: 19 start-page: 92 year: 2009 end-page: 105 ident: bib77 article-title: Most mammalian mRNAs are conserved targets of microRNAs publication-title: Genome Res. – volume: 313 start-page: 51 year: 1996 end-page: 55 ident: bib88 article-title: Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms publication-title: Biochem. J. – volume: 96 start-page: 2000 year: 2015 end-page: 2027 ident: bib130 article-title: Viroporins: structure, function and potential as antiviral targets publication-title: J. Gen. Virol. – volume: 67 start-page: 4521 year: 1993 end-page: 4532 ident: bib113 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. – volume: 9 year: 2017 ident: bib31 article-title: Keratinocyte differentiation-dependent human papillomavirus gene regulation publication-title: Viruses – volume: 146 start-page: 682 year: 2011 end-page: 695 ident: bib90 article-title: Autophagy and aging publication-title: Cell – volume: 458–459 start-page: 93 year: 2014 end-page: 105 ident: bib24 article-title: The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network publication-title: Virology – volume: 26 start-page: 42 year: 2007 end-page: 53 ident: bib47 article-title: ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein publication-title: Oncogene – volume: 399 start-page: 617 year: 2010 end-page: 622 ident: bib76 article-title: The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes publication-title: Biochem. Biophys. Res. Commun. – volume: 13 start-page: 5451 year: 1994 end-page: 5459 ident: bib16 article-title: Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes publication-title: EMBO J. – volume: 158 start-page: 113 year: 2018 end-page: 121 ident: bib132 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. – volume: 19 start-page: 189 year: 2015 end-page: 193 ident: bib118 article-title: Aspirin and acetaminophen use and the risk of cervical cancer publication-title: J. Low. Genit. Tract Dis. – volume: 204 start-page: 566 year: 2011 end-page: 573 ident: bib6 article-title: Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006 publication-title: J. Infect. Dis. – volume: 47 start-page: 14 year: 2018 end-page: 26 ident: bib4 article-title: Epidemiology and burden of HPV-related disease publication-title: Best Pract. Res. Clin. Obstet. Gynaecol. – volume: 21 start-page: 5817 year: 1993 end-page: 5823 ident: bib15 article-title: E1 protein of human papillomavirus is a DNA helicase/ATPase publication-title: Nucleic Acids Res. – volume: 384 start-page: 125 year: 2009 end-page: 134 ident: bib84 article-title: Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion publication-title: Virology – volume: 519 start-page: 1 year: 2018 end-page: 11 ident: bib59 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology – volume: 18 start-page: 807 year: 2012 end-page: 815 ident: bib112 article-title: Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer publication-title: J. Infect. Chemother. – volume: 44 start-page: 381 year: 2004 end-page: 386 ident: bib100 article-title: Modulation of oxidant and antioxidant enzyme expression and function in vascular cells publication-title: Hypertension – volume: 158 start-page: 113 year: 2018 end-page: 121 ident: bib64 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. – volume: 27 start-page: 2616 year: 2008 end-page: 2627 ident: bib82 article-title: Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells publication-title: EMBO J. – volume: 6 start-page: 45 year: 2011 end-page: 57 ident: bib14 article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress publication-title: Future Virol. – volume: 37 start-page: 1561 year: 2018 end-page: 1575 ident: bib96 article-title: Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies publication-title: Oncogene – volume: 84 start-page: 10619 year: 2010 end-page: 10629 ident: bib49 article-title: The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification publication-title: J. Virol. – volume: 10 start-page: 550 year: 2010 end-page: 560 ident: bib11 article-title: Human papillomavirus oncoproteins: pathways to transformation publication-title: Nat. Rev. Cancer – volume: 8 start-page: 1492 year: 2014 end-page: 1498 ident: bib92 article-title: Reduced expression of autophagy markers correlates with high-risk human papillomavirus infection in human cervical squamous cell carcinoma publication-title: Oncol. Lett. – volume: 136 start-page: 215 year: 2009 end-page: 233 ident: bib79 article-title: MicroRNAs: target recognition and regulatory functions publication-title: Cell – volume: 2014 year: 2014 ident: bib106 article-title: The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid publication-title: Pathol. Res. Int. – volume: 67 start-page: 3976 year: 2007 end-page: 3985 ident: bib110 article-title: Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange publication-title: Cancer Res. – volume: 160 start-page: 389 year: 2015 end-page: 398 ident: bib32 article-title: Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins publication-title: Arch. Virol. – volume: 63 start-page: 930 year: 2006 end-page: 938 ident: bib52 article-title: Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt publication-title: Cell. Mol. Life Sci. – volume: 67 start-page: 4521 year: 1993 end-page: 4532 ident: bib71 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. – volume: 69 start-page: 4489 year: 1995 end-page: 4494 ident: bib73 article-title: Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line publication-title: J. Virol. – volume: 18 start-page: 123 year: 2013 end-page: 134 ident: bib116 article-title: Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia publication-title: J Cancer Prev – volume: 120 start-page: 13076 year: 2016 end-page: 13085 ident: bib128 article-title: Weak selectivity predicted for modeled bundles of viral channel-forming protein E5 of human papillomavirus-16 publication-title: J. Phys. Chem. B – volume: 76 start-page: 12162 year: 2002 end-page: 12172 ident: bib69 article-title: The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms publication-title: J. Virol. – volume: 70 start-page: 7535 year: 1996 end-page: 7539 ident: bib74 article-title: Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. – volume: 111 start-page: 15544 year: 2014 end-page: 15549 ident: bib10 article-title: Characterization of HPV and host genome interactions in primary head and neck cancers publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 140 start-page: 3079 year: 2013 end-page: 3093 ident: bib104 article-title: Cdks, cyclins and CKIs: roles beyond cell cycle regulation publication-title: Development – volume: 27 start-page: 2532 year: 2008 end-page: 2541 ident: bib70 article-title: Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression publication-title: Oncogene – volume: 158 start-page: 113 year: 2018 end-page: 121 ident: bib41 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. – volume: 519 start-page: 1 year: 2018 end-page: 11 ident: bib54 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology – volume: 25 start-page: 2 year: 2015 end-page: 23 ident: bib22 article-title: Human papillomavirus molecular biology and disease association publication-title: Rev. Med. Virol. – volume: 12 start-page: 38 year: 2013 ident: bib58 article-title: Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway publication-title: Mol. Cancer – volume: 302 start-page: 183 year: 1993 end-page: 192 ident: bib62 article-title: Isolation and characterization of a differentiation-dependent gene in the human colonic cell line HT29-18 publication-title: Arch. Biochem. Biophys. – volume: 7 start-page: 5375 year: 2015 end-page: 5387 ident: bib129 article-title: Emerging roles of viroporins encoded by DNA viruses: novel targets for antivirals? publication-title: Viruses – volume: 519 start-page: 1 year: 2018 end-page: 11 ident: bib48 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology – volume: 5 start-page: 7653 year: 2015 ident: bib83 article-title: HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells publication-title: Sci. Rep. – volume: 86 start-page: 5341 year: 2012 end-page: 5351 ident: bib131 article-title: High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors publication-title: J. Virol. – volume: 30 start-page: 753 year: 2009 end-page: 757 ident: bib115 article-title: Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein publication-title: Carcinogenesis – volume: 55 start-page: 570 year: 2019 end-page: 584 ident: bib127 article-title: Current strategies against persistent human papillomavirus infection publication-title: Int. J. Oncol. – volume: 400 start-page: 44 year: 2010 end-page: 52 ident: bib51 article-title: The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1) publication-title: Virology – volume: 77 year: 2019 ident: bib107 article-title: Association of human papillomavirus infection and inflammation in cervical cancer publication-title: Pathog Dis – volume: 23 start-page: 7276 year: 2017 end-page: 7287 ident: bib117 article-title: Demethylation therapy as a targeted treatment for human papillomavirus-associated head and neck cancer publication-title: Clin. Cancer Res. – volume: 3 start-page: 524 year: 2017 end-page: 548 ident: bib1 article-title: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study publication-title: JAMA Oncol. – volume: 445 start-page: 57 year: 2013 end-page: 79 ident: bib27 article-title: The papillomavirus E2 proteins publication-title: Virology – volume: 72 start-page: 26 year: 2018 end-page: 30 ident: bib5 article-title: Prevalence of specific types of human papiloma virus in cervical intraepithelial lesions and cervical cancer in Macedonian women publication-title: Med. Arch. – volume: 67 start-page: 4521 year: 1993 end-page: 4532 ident: bib95 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. – volume: 13 start-page: 291 year: 2017 end-page: 297 ident: bib124 article-title: HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy publication-title: Hum. Vaccines Immunother. – volume: 231 start-page: 103 year: 2017 end-page: 107 ident: bib28 article-title: Papillomavirus assembly: an overview and perspectives publication-title: Virus Res. – volume: 5 start-page: 1493 year: 2010 end-page: 1506 ident: bib18 article-title: Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies publication-title: Future Microbiol. – volume: 301 start-page: 1365 year: 2020 end-page: 1375 ident: bib98 article-title: COX-2-PGE(2)-EPs in gynecological cancers publication-title: Arch. Gynecol. Obstet. – volume: 16 year: 2020 ident: bib126 article-title: Targeting HPV in gynaecological cancers - current status, ongoing challenges and future directions publication-title: Women's Health – volume: 19 start-page: 167 year: 2021 end-page: 179 ident: bib108 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. – volume: 24 start-page: 2585 year: 2005 end-page: 2588 ident: bib50 article-title: HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes publication-title: Oncogene – volume: 76 start-page: 220 year: 2002 end-page: 231 ident: bib67 article-title: E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis publication-title: J. Virol. – volume: 223 start-page: 251 year: 1996 end-page: 254 ident: bib72 article-title: The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA publication-title: Virology – volume: 23 start-page: 432 year: 2014 end-page: 448 ident: bib109 article-title: Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention publication-title: Eur. J. Cancer Prev. – volume: 7 start-page: 5375 year: 2015 end-page: 5387 ident: bib63 article-title: Emerging roles of viroporins encoded by DNA viruses: novel targets for antivirals? publication-title: Viruses – volume: 7 start-page: 411 year: 2005 end-page: 423 ident: bib114 article-title: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent publication-title: Cancer Cell – volume: 205 start-page: 35 year: 2008 end-page: 42 ident: bib39 article-title: Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses publication-title: J. Exp. Med. – volume: 445 start-page: 35 year: 2013 end-page: 56 ident: bib26 article-title: The E1 proteins publication-title: Virology – volume: 2 year: 2016 ident: bib86 article-title: Carcinogenic human papillomavirus infection publication-title: Nat. Rev. Dis. Prim. – volume: 2018 year: 2018 ident: bib97 article-title: New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress publication-title: J Immunol Res – volume: 103 start-page: 425 year: 2006 end-page: 430 ident: bib120 article-title: A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia publication-title: Gynecol. Oncol. – volume: 139 year: 2020 ident: bib34 article-title: Impact of HPV E5 on viral life cycle via EGFR signaling publication-title: Microb. Pathog. – volume: 65 start-page: 6534 year: 2005 end-page: 6542 ident: bib46 article-title: Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene publication-title: Cancer Res. – volume: 36 start-page: 71 year: 2017 ident: bib20 article-title: hrHPV E5 oncoprotein: immune evasion and related immunotherapies publication-title: J. Exp. Clin. Cancer Res. – volume: 445 start-page: 80 year: 2013 end-page: 98 ident: bib17 article-title: The E4 protein; structure, function and patterns of expression publication-title: Virology – volume: 19 year: 2018 ident: bib94 article-title: Regulation of cellular metabolism by high-risk human papillomaviruses publication-title: Int. J. Mol. Sci. – volume: 30 start-page: 141 year: 2009 end-page: 149 ident: bib111 article-title: Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells publication-title: Carcinogenesis – volume: 17 start-page: 431 year: 2007 end-page: 437 ident: bib85 article-title: A virus causes cancer by inducing massive chromosomal instability through cell fusion publication-title: Curr. Biol. – volume: 15 start-page: 310 year: 2014 end-page: 323 ident: bib78 article-title: A comprehensive review of dysregulated miRNAs involved in cervical cancer publication-title: Curr. Genom. – volume: 83 start-page: 12833 year: 2009 end-page: 12841 ident: bib75 article-title: The canine papillomavirus e5 protein signals from the endoplasmic reticulum publication-title: J. Virol. – volume: 212 start-page: 65 e1 year: 2015 end-page: e5 ident: bib3 article-title: Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women publication-title: Am. J. Obstet. Gynecol. – volume: 37 start-page: 278 year: 2016 end-page: 285 ident: bib9 article-title: Burden of cervical cancer and role of screening in India publication-title: Indian J. Med. Paediatr. Oncol. – volume: 19 start-page: 167 year: 2021 end-page: 179 ident: bib44 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. – volume: 70 start-page: 7535 year: 1996 end-page: 7539 ident: bib105 article-title: Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. – volume: 228 start-page: 148 year: 2012 end-page: 157 ident: bib122 article-title: Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells publication-title: J. Pathol. – volume: 78 start-page: 1333 year: 2004 end-page: 1343 ident: bib123 article-title: Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice publication-title: J. Virol. – volume: 31 start-page: 766 year: 2010 end-page: 776 ident: bib81 article-title: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma publication-title: Carcinogenesis – volume: 405 start-page: 342 year: 2010 end-page: 351 ident: bib65 article-title: Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication publication-title: Virology – volume: 18 start-page: 233 year: 2007 end-page: 240 ident: bib121 article-title: Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis publication-title: Ann. Oncol. – volume: 36 start-page: 71 year: 2017 ident: bib125 article-title: hrHPV E5 oncoprotein: immune evasion and related immunotherapies publication-title: J. Exp. Clin. Cancer Res. – volume: 6 start-page: 19 year: 2006 ident: bib13 article-title: Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts publication-title: Cancer Cell Int. – volume: 6 start-page: 9370 year: 2015 end-page: 9386 ident: bib93 article-title: HPV16 E5 deregulates the autophagic process in human keratinocytes publication-title: Oncotarget – volume: 93 year: 2019 ident: bib55 article-title: Suppression of stromal interferon signaling by human papillomavirus 16 publication-title: J. Virol. – volume: 10 start-page: 2574 year: 2015 end-page: 2578 ident: bib119 article-title: Anti-inflammatory drugs and uterine cervical cancer cells: antineoplastic effect of meclofenamic acid publication-title: Oncol. Lett. – volume: 6 year: 2011 ident: bib80 article-title: Human papillomavirus 16 E5 modulates the expression of host microRNAs publication-title: PLoS One – volume: 1601 start-page: 9 year: 2002 end-page: 18 ident: bib43 article-title: Modelling of the human papillomavirus type 16 E5 protein publication-title: Biochim. Biophys. Acta – volume: 47 start-page: 48 year: 2004 end-page: 56 ident: bib68 article-title: The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures publication-title: Intervirology – volume: 137 start-page: 61 year: 2015 end-page: 72 ident: bib53 article-title: HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition publication-title: Int. J. Cancer – volume: 371 start-page: 684 year: 2008 end-page: 688 ident: bib37 article-title: Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein publication-title: Biochem. Biophys. Res. Commun. – volume: 15 year: 2023 ident: bib35 article-title: Human papillomavirus genomics: understanding carcinogenicity publication-title: Tumour Virus Res – volume: 94 year: 2020 ident: bib56 article-title: Human papillomavirus 16 E5 inhibits interferon signaling and supports episomal viral maintenance publication-title: J. Virol. – volume: 31 start-page: 553 year: 2012 end-page: 568 ident: bib57 article-title: TGF-beta signalling and its role in cancer progression and metastasis publication-title: Cancer Metastasis Rev. – volume: 405 start-page: 342 year: 2010 end-page: 351 ident: bib89 article-title: Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication publication-title: Virology – volume: 30 start-page: 1 year: 2003 end-page: 10 ident: bib36 article-title: Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16 publication-title: Protein Expr. Purif. – volume: 119 start-page: 2105 year: 2006 end-page: 2112 ident: bib40 article-title: E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain publication-title: Int. J. Cancer – volume: 223 start-page: 251 issue: 1 year: 1996 ident: 10.1016/j.abb.2023.109716_bib72 article-title: The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA publication-title: Virology doi: 10.1006/viro.1996.0475 – volume: 55 start-page: 570 issue: 3 year: 2019 ident: 10.1016/j.abb.2023.109716_bib127 article-title: Current strategies against persistent human papillomavirus infection publication-title: Int. J. Oncol. – volume: 18 start-page: 3319 issue: 12 year: 2017 ident: 10.1016/j.abb.2023.109716_bib2 article-title: Almost complete lack of human cytomegalovirus and human papillomaviruses genome in benign and malignant breast lesions in shiraz, southwest of Iran publication-title: Asian Pac. J. Cancer Prev. APJCP – volume: 519 start-page: 1 year: 2018 ident: 10.1016/j.abb.2023.109716_bib54 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology doi: 10.1016/j.virol.2018.03.021 – volume: 30 start-page: 1 issue: 1 year: 2003 ident: 10.1016/j.abb.2023.109716_bib36 article-title: Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16 publication-title: Protein Expr. Purif. doi: 10.1016/S1046-5928(03)00049-4 – volume: 19 start-page: 167 issue: 2 year: 2021 ident: 10.1016/j.abb.2023.109716_bib44 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-20-0491 – volume: 31 start-page: 553 issue: 3–4 year: 2012 ident: 10.1016/j.abb.2023.109716_bib57 article-title: TGF-beta signalling and its role in cancer progression and metastasis publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-012-9375-7 – volume: 400 start-page: 44 issue: 1 year: 2010 ident: 10.1016/j.abb.2023.109716_bib51 article-title: The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1) publication-title: Virology doi: 10.1016/j.virol.2010.01.009 – volume: 19 start-page: 92 issue: 1 year: 2009 ident: 10.1016/j.abb.2023.109716_bib77 article-title: Most mammalian mRNAs are conserved targets of microRNAs publication-title: Genome Res. doi: 10.1101/gr.082701.108 – volume: 6 start-page: 9370 issue: 11 year: 2015 ident: 10.1016/j.abb.2023.109716_bib93 article-title: HPV16 E5 deregulates the autophagic process in human keratinocytes publication-title: Oncotarget doi: 10.18632/oncotarget.3326 – volume: 18 start-page: 123 issue: 2 year: 2013 ident: 10.1016/j.abb.2023.109716_bib116 article-title: Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia publication-title: J Cancer Prev doi: 10.15430/JCP.2013.18.2.123 – volume: 27 start-page: 2616 issue: 19 year: 2008 ident: 10.1016/j.abb.2023.109716_bib82 article-title: Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells publication-title: EMBO J. doi: 10.1038/emboj.2008.172 – volume: 47 start-page: 48 issue: 1 year: 2004 ident: 10.1016/j.abb.2023.109716_bib68 article-title: The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures publication-title: Intervirology doi: 10.1159/000076642 – volume: 15 start-page: 310 issue: 4 year: 2014 ident: 10.1016/j.abb.2023.109716_bib78 article-title: A comprehensive review of dysregulated miRNAs involved in cervical cancer publication-title: Curr. Genom. doi: 10.2174/1389202915666140528003249 – volume: 85 start-page: 10968 issue: 21 year: 2011 ident: 10.1016/j.abb.2023.109716_bib87 article-title: The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region publication-title: J. Virol. doi: 10.1128/JVI.00706-11 – volume: 15 year: 2023 ident: 10.1016/j.abb.2023.109716_bib35 article-title: Human papillomavirus genomics: understanding carcinogenicity publication-title: Tumour Virus Res doi: 10.1016/j.tvr.2023.200258 – volume: 86 start-page: 5341 issue: 9 year: 2012 ident: 10.1016/j.abb.2023.109716_bib131 article-title: High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors publication-title: J. Virol. doi: 10.1128/JVI.06243-11 – volume: 23 start-page: 7276 issue: 23 year: 2017 ident: 10.1016/j.abb.2023.109716_bib117 article-title: Demethylation therapy as a targeted treatment for human papillomavirus-associated head and neck cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-1438 – volume: 100 start-page: 407 issue: 6 year: 2008 ident: 10.1016/j.abb.2023.109716_bib8 article-title: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djn025 – volume: 37 start-page: 1561 issue: 12 year: 2018 ident: 10.1016/j.abb.2023.109716_bib96 article-title: Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies publication-title: Oncogene doi: 10.1038/s41388-017-0045-7 – volume: 7 start-page: 5375 issue: 10 year: 2015 ident: 10.1016/j.abb.2023.109716_bib129 article-title: Emerging roles of viroporins encoded by DNA viruses: novel targets for antivirals? publication-title: Viruses doi: 10.3390/v7102880 – volume: 103 start-page: 425 issue: 2 year: 2006 ident: 10.1016/j.abb.2023.109716_bib120 article-title: A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2006.03.036 – volume: 131 start-page: 2201 issue: 17 year: 2017 ident: 10.1016/j.abb.2023.109716_bib25 article-title: The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review publication-title: Clin. Sci. (Lond.) doi: 10.1042/CS20160786 – volume: 83 start-page: 12833 issue: 24 year: 2009 ident: 10.1016/j.abb.2023.109716_bib75 article-title: The canine papillomavirus e5 protein signals from the endoplasmic reticulum publication-title: J. Virol. doi: 10.1128/JVI.01003-09 – volume: 117 start-page: S5 issue: 2 Suppl year: 2010 ident: 10.1016/j.abb.2023.109716_bib7 article-title: Pathology and epidemiology of HPV infection in females publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2010.01.024 – volume: 78 start-page: 1333 issue: 3 year: 2004 ident: 10.1016/j.abb.2023.109716_bib123 article-title: Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice publication-title: J. Virol. doi: 10.1128/JVI.78.3.1333-1343.2004 – volume: 25 start-page: 2 issue: Suppl 1 year: 2015 ident: 10.1016/j.abb.2023.109716_bib22 article-title: Human papillomavirus molecular biology and disease association publication-title: Rev. Med. Virol. doi: 10.1002/rmv.1822 – volume: 158 start-page: 113 year: 2018 ident: 10.1016/j.abb.2023.109716_bib41 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2018.08.005 – volume: 30 start-page: 141 issue: 1 year: 2009 ident: 10.1016/j.abb.2023.109716_bib111 article-title: Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgn236 – volume: 67 start-page: 4521 issue: 8 year: 1993 ident: 10.1016/j.abb.2023.109716_bib95 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.67.8.4521-4532.1993 – volume: 31 start-page: 402 issue: 3 year: 2010 ident: 10.1016/j.abb.2023.109716_bib66 article-title: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgp318 – volume: 76 start-page: 12162 issue: 23 year: 2002 ident: 10.1016/j.abb.2023.109716_bib69 article-title: The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms publication-title: J. Virol. doi: 10.1128/JVI.76.23.12162-12172.2002 – volume: 67 start-page: 4521 issue: 8 year: 1993 ident: 10.1016/j.abb.2023.109716_bib71 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.67.8.4521-4532.1993 – volume: 23 start-page: 432 issue: 5 year: 2014 ident: 10.1016/j.abb.2023.109716_bib109 article-title: Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention publication-title: Eur. J. Cancer Prev. doi: 10.1097/CEJ.0000000000000023 – volume: 86 start-page: 5341 issue: 9 year: 2012 ident: 10.1016/j.abb.2023.109716_bib42 article-title: High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors publication-title: J. Virol. doi: 10.1128/JVI.06243-11 – volume: 47 start-page: 14 year: 2018 ident: 10.1016/j.abb.2023.109716_bib4 article-title: Epidemiology and burden of HPV-related disease publication-title: Best Pract. Res. Clin. Obstet. Gynaecol. doi: 10.1016/j.bpobgyn.2017.08.006 – volume: 70 start-page: 7535 issue: 11 year: 1996 ident: 10.1016/j.abb.2023.109716_bib105 article-title: Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.70.11.7535-7539.1996 – volume: 231 start-page: 103 year: 2017 ident: 10.1016/j.abb.2023.109716_bib28 article-title: Papillomavirus assembly: an overview and perspectives publication-title: Virus Res. doi: 10.1016/j.virusres.2016.11.010 – volume: 2 year: 2016 ident: 10.1016/j.abb.2023.109716_bib86 article-title: Carcinogenic human papillomavirus infection publication-title: Nat. Rev. Dis. Prim. – volume: 19 issue: 7 year: 2018 ident: 10.1016/j.abb.2023.109716_bib94 article-title: Regulation of cellular metabolism by high-risk human papillomaviruses publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19071839 – volume: 119 start-page: 2105 issue: 9 year: 2006 ident: 10.1016/j.abb.2023.109716_bib40 article-title: E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain publication-title: Int. J. Cancer doi: 10.1002/ijc.22089 – volume: 93 issue: 19 year: 2019 ident: 10.1016/j.abb.2023.109716_bib55 article-title: Suppression of stromal interferon signaling by human papillomavirus 16 publication-title: J. Virol. doi: 10.1128/JVI.00458-19 – volume: 445 start-page: 57 issue: 1–2 year: 2013 ident: 10.1016/j.abb.2023.109716_bib27 article-title: The papillomavirus E2 proteins publication-title: Virology doi: 10.1016/j.virol.2013.06.006 – volume: 160 start-page: 389 issue: 2 year: 2015 ident: 10.1016/j.abb.2023.109716_bib32 article-title: Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins publication-title: Arch. Virol. doi: 10.1007/s00705-014-2305-y – volume: 1601 start-page: 9 issue: 1 year: 2002 ident: 10.1016/j.abb.2023.109716_bib43 article-title: Modelling of the human papillomavirus type 16 E5 protein publication-title: Biochim. Biophys. Acta doi: 10.1016/S1570-9639(02)00408-9 – volume: 6 start-page: 45 issue: 1 year: 2011 ident: 10.1016/j.abb.2023.109716_bib14 article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress publication-title: Future Virol. doi: 10.2217/fvl.10.73 – volume: 205 start-page: 35 issue: 1 year: 2008 ident: 10.1016/j.abb.2023.109716_bib39 article-title: Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses publication-title: J. Exp. Med. doi: 10.1084/jem.20071311 – volume: 94 issue: 2 year: 2020 ident: 10.1016/j.abb.2023.109716_bib56 article-title: Human papillomavirus 16 E5 inhibits interferon signaling and supports episomal viral maintenance publication-title: J. Virol. doi: 10.1128/JVI.01582-19 – volume: 19 start-page: 189 issue: 3 year: 2015 ident: 10.1016/j.abb.2023.109716_bib118 article-title: Aspirin and acetaminophen use and the risk of cervical cancer publication-title: J. Low. Genit. Tract Dis. doi: 10.1097/LGT.0000000000000104 – volume: 102 issue: 3 year: 2021 ident: 10.1016/j.abb.2023.109716_bib102 article-title: The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001540 – volume: 10 start-page: 2574 issue: 4 year: 2015 ident: 10.1016/j.abb.2023.109716_bib119 article-title: Anti-inflammatory drugs and uterine cervical cancer cells: antineoplastic effect of meclofenamic acid publication-title: Oncol. Lett. doi: 10.3892/ol.2015.3580 – volume: 24 start-page: 2585 issue: 15 year: 2005 ident: 10.1016/j.abb.2023.109716_bib50 article-title: HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes publication-title: Oncogene doi: 10.1038/sj.onc.1208453 – volume: 27 start-page: 2532 issue: 18 year: 2008 ident: 10.1016/j.abb.2023.109716_bib70 article-title: Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression publication-title: Oncogene doi: 10.1038/sj.onc.1210916 – volume: 5 start-page: 7653 year: 2015 ident: 10.1016/j.abb.2023.109716_bib83 article-title: HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells publication-title: Sci. Rep. doi: 10.1038/srep07653 – volume: 31 start-page: 766 issue: 5 year: 2010 ident: 10.1016/j.abb.2023.109716_bib81 article-title: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma publication-title: Carcinogenesis doi: 10.1093/carcin/bgp250 – volume: 77 issue: 5 year: 2019 ident: 10.1016/j.abb.2023.109716_bib107 article-title: Association of human papillomavirus infection and inflammation in cervical cancer publication-title: Pathog Dis doi: 10.1093/femspd/ftz048 – volume: 96 start-page: 2000 issue: 8 year: 2015 ident: 10.1016/j.abb.2023.109716_bib130 article-title: Viroporins: structure, function and potential as antiviral targets publication-title: J. Gen. Virol. doi: 10.1099/vir.0.000201 – volume: 70 start-page: 2924 issue: 7 year: 2010 ident: 10.1016/j.abb.2023.109716_bib21 article-title: A role for HPV16 E5 in cervical carcinogenesis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3436 – volume: 13 start-page: 5451 issue: 22 year: 1994 ident: 10.1016/j.abb.2023.109716_bib16 article-title: Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes publication-title: EMBO J. doi: 10.1002/j.1460-2075.1994.tb06880.x – volume: 313 start-page: 51 issue: Pt 1 year: 1996 ident: 10.1016/j.abb.2023.109716_bib88 article-title: Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms publication-title: Biochem. J. doi: 10.1042/bj3130051 – volume: 7 start-page: 411 issue: 5 year: 2005 ident: 10.1016/j.abb.2023.109716_bib114 article-title: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.04.014 – volume: 111 start-page: 15544 issue: 43 year: 2014 ident: 10.1016/j.abb.2023.109716_bib10 article-title: Characterization of HPV and host genome interactions in primary head and neck cancers publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1416074111 – volume: 158 start-page: 113 year: 2018 ident: 10.1016/j.abb.2023.109716_bib132 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2018.08.005 – volume: 384 start-page: 125 issue: 1 year: 2009 ident: 10.1016/j.abb.2023.109716_bib84 article-title: Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion publication-title: Virology doi: 10.1016/j.virol.2008.10.011 – volume: 193 start-page: 135 year: 2014 ident: 10.1016/j.abb.2023.109716_bib19 article-title: The role of human papillomaviruses in oncogenesis publication-title: Recent Results Cancer Res. doi: 10.1007/978-3-642-38965-8_8 – volume: 22 issue: 17 year: 2021 ident: 10.1016/j.abb.2023.109716_bib33 article-title: K-mer analyses reveal different evolutionary histories of alpha, beta, and gamma papillomaviruses publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22179657 – volume: 11 start-page: 59 year: 2016 ident: 10.1016/j.abb.2023.109716_bib29 article-title: Molecular mechanisms of HPV mediated neoplastic progression publication-title: Infect. Agents Cancer doi: 10.1186/s13027-016-0107-4 – volume: 76 start-page: 220 issue: 1 year: 2002 ident: 10.1016/j.abb.2023.109716_bib67 article-title: E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis publication-title: J. Virol. doi: 10.1128/JVI.76.1.220-231.2002 – volume: 36 start-page: 71 issue: 1 year: 2017 ident: 10.1016/j.abb.2023.109716_bib20 article-title: hrHPV E5 oncoprotein: immune evasion and related immunotherapies publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-017-0541-1 – volume: 146 start-page: 682 issue: 5 year: 2011 ident: 10.1016/j.abb.2023.109716_bib90 article-title: Autophagy and aging publication-title: Cell doi: 10.1016/j.cell.2011.07.030 – volume: 70 start-page: 7535 issue: 11 year: 1996 ident: 10.1016/j.abb.2023.109716_bib74 article-title: Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.70.11.7535-7539.1996 – volume: 7 start-page: 5375 issue: 10 year: 2015 ident: 10.1016/j.abb.2023.109716_bib63 article-title: Emerging roles of viroporins encoded by DNA viruses: novel targets for antivirals? publication-title: Viruses doi: 10.3390/v7102880 – volume: 65 start-page: 6534 issue: 15 year: 2005 ident: 10.1016/j.abb.2023.109716_bib46 article-title: Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-0083 – volume: 399 start-page: 617 issue: 4 year: 2010 ident: 10.1016/j.abb.2023.109716_bib76 article-title: The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2010.07.125 – volume: 115 year: 2020 ident: 10.1016/j.abb.2023.109716_bib99 article-title: Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state publication-title: Mem. Inst. Oswaldo Cruz doi: 10.1590/0074-02760190405 – volume: 371 start-page: 684 issue: 4 year: 2008 ident: 10.1016/j.abb.2023.109716_bib37 article-title: Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2008.04.122 – volume: 21 start-page: 5817 issue: 25 year: 1993 ident: 10.1016/j.abb.2023.109716_bib15 article-title: E1 protein of human papillomavirus is a DNA helicase/ATPase publication-title: Nucleic Acids Res. doi: 10.1093/nar/21.25.5817 – volume: 63 start-page: 930 issue: 7–8 year: 2006 ident: 10.1016/j.abb.2023.109716_bib52 article-title: Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-005-5561-x – volume: 405 start-page: 342 issue: 2 year: 2010 ident: 10.1016/j.abb.2023.109716_bib65 article-title: Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication publication-title: Virology doi: 10.1016/j.virol.2010.06.025 – volume: 136 start-page: 215 issue: 2 year: 2009 ident: 10.1016/j.abb.2023.109716_bib79 article-title: MicroRNAs: target recognition and regulatory functions publication-title: Cell doi: 10.1016/j.cell.2009.01.002 – volume: 137 start-page: 61 issue: 1 year: 2015 ident: 10.1016/j.abb.2023.109716_bib53 article-title: HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition publication-title: Int. J. Cancer doi: 10.1002/ijc.29373 – volume: 10 start-page: 550 issue: 8 year: 2010 ident: 10.1016/j.abb.2023.109716_bib11 article-title: Human papillomavirus oncoproteins: pathways to transformation publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2886 – volume: 8 issue: 4 year: 2012 ident: 10.1016/j.abb.2023.109716_bib23 article-title: Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1002657 – volume: 37 start-page: 278 issue: 4 year: 2016 ident: 10.1016/j.abb.2023.109716_bib9 article-title: Burden of cervical cancer and role of screening in India publication-title: Indian J. Med. Paediatr. Oncol. doi: 10.4103/0971-5851.195751 – volume: 9 issue: 3 year: 2013 ident: 10.1016/j.abb.2023.109716_bib103 article-title: The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003237 – volume: 31 start-page: 402 issue: 3 year: 2010 ident: 10.1016/j.abb.2023.109716_bib101 article-title: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgp318 – volume: 139 year: 2020 ident: 10.1016/j.abb.2023.109716_bib34 article-title: Impact of HPV E5 on viral life cycle via EGFR signaling publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2019.103923 – volume: 19 start-page: 167 issue: 2 year: 2021 ident: 10.1016/j.abb.2023.109716_bib45 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-20-0491 – volume: 158 start-page: 113 year: 2018 ident: 10.1016/j.abb.2023.109716_bib64 article-title: Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2018.08.005 – volume: 204 start-page: 566 issue: 4 year: 2011 ident: 10.1016/j.abb.2023.109716_bib6 article-title: Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jir341 – volume: 212 start-page: 65 e1 issue: 1 year: 2015 ident: 10.1016/j.abb.2023.109716_bib3 article-title: Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/j.ajog.2014.06.059 – volume: 17 start-page: 431 issue: 5 year: 2007 ident: 10.1016/j.abb.2023.109716_bib85 article-title: A virus causes cancer by inducing massive chromosomal instability through cell fusion publication-title: Curr. Biol. doi: 10.1016/j.cub.2007.01.049 – volume: 5 start-page: 1493 issue: 10 year: 2010 ident: 10.1016/j.abb.2023.109716_bib18 article-title: Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies publication-title: Future Microbiol. doi: 10.2217/fmb.10.107 – volume: 84 start-page: 10619 issue: 20 year: 2010 ident: 10.1016/j.abb.2023.109716_bib49 article-title: The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification publication-title: J. Virol. doi: 10.1128/JVI.00831-10 – volume: 31 start-page: 473 issue: 3 year: 2010 ident: 10.1016/j.abb.2023.109716_bib60 article-title: Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgp281 – volume: 14 start-page: 87 year: 2015 ident: 10.1016/j.abb.2023.109716_bib12 article-title: The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses publication-title: Mol. Cancer doi: 10.1186/s12943-015-0361-x – volume: 6 issue: 7 year: 2011 ident: 10.1016/j.abb.2023.109716_bib80 article-title: Human papillomavirus 16 E5 modulates the expression of host microRNAs publication-title: PLoS One doi: 10.1371/journal.pone.0021646 – volume: 44 start-page: 381 issue: 4 year: 2004 ident: 10.1016/j.abb.2023.109716_bib100 article-title: Modulation of oxidant and antioxidant enzyme expression and function in vascular cells publication-title: Hypertension doi: 10.1161/01.HYP.0000142232.29764.a7 – volume: 36 start-page: 71 issue: 1 year: 2017 ident: 10.1016/j.abb.2023.109716_bib125 article-title: hrHPV E5 oncoprotein: immune evasion and related immunotherapies publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-017-0541-1 – volume: 120 start-page: 13076 issue: 51 year: 2016 ident: 10.1016/j.abb.2023.109716_bib128 article-title: Weak selectivity predicted for modeled bundles of viral channel-forming protein E5 of human papillomavirus-16 publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.6b10050 – volume: 519 start-page: 1 year: 2018 ident: 10.1016/j.abb.2023.109716_bib48 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology doi: 10.1016/j.virol.2018.03.021 – volume: 519 start-page: 1 year: 2018 ident: 10.1016/j.abb.2023.109716_bib59 article-title: Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes publication-title: Virology doi: 10.1016/j.virol.2018.03.021 – volume: 82 start-page: 10042 issue: 20 year: 2008 ident: 10.1016/j.abb.2023.109716_bib38 article-title: Bap31 is a novel target of the human papillomavirus E5 protein publication-title: J. Virol. doi: 10.1128/JVI.01240-08 – volume: 458–459 start-page: 93 year: 2014 ident: 10.1016/j.abb.2023.109716_bib24 article-title: The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network publication-title: Virology doi: 10.1016/j.virol.2014.04.024 – volume: 228 start-page: 148 issue: 2 year: 2012 ident: 10.1016/j.abb.2023.109716_bib122 article-title: Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells publication-title: J. Pathol. doi: 10.1002/path.3997 – volume: 445 start-page: 35 issue: 1–2 year: 2013 ident: 10.1016/j.abb.2023.109716_bib26 article-title: The E1 proteins publication-title: Virology doi: 10.1016/j.virol.2013.07.020 – volume: 2014 year: 2014 ident: 10.1016/j.abb.2023.109716_bib106 article-title: The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid publication-title: Pathol. Res. Int. doi: 10.1155/2014/748740 – volume: 16 year: 2020 ident: 10.1016/j.abb.2023.109716_bib126 article-title: Targeting HPV in gynaecological cancers - current status, ongoing challenges and future directions publication-title: Women's Health doi: 10.1177/1745506520961709 – volume: 405 start-page: 342 issue: 2 year: 2010 ident: 10.1016/j.abb.2023.109716_bib89 article-title: Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication publication-title: Virology doi: 10.1016/j.virol.2010.06.025 – volume: 3 start-page: 524 issue: 4 year: 2017 ident: 10.1016/j.abb.2023.109716_bib1 article-title: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2016.5688 – volume: 2018 year: 2018 ident: 10.1016/j.abb.2023.109716_bib97 article-title: New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress publication-title: J Immunol Res doi: 10.1155/2018/5315816 – volume: 302 start-page: 183 issue: 1 year: 1993 ident: 10.1016/j.abb.2023.109716_bib62 article-title: Isolation and characterization of a differentiation-dependent gene in the human colonic cell line HT29-18 publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.1993.1197 – volume: 445 start-page: 80 issue: 1–2 year: 2013 ident: 10.1016/j.abb.2023.109716_bib17 article-title: The E4 protein; structure, function and patterns of expression publication-title: Virology doi: 10.1016/j.virol.2013.07.008 – volume: 26 start-page: 42 issue: 1 year: 2007 ident: 10.1016/j.abb.2023.109716_bib47 article-title: ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein publication-title: Oncogene doi: 10.1038/sj.onc.1209768 – volume: 67 start-page: 3976 issue: 8 year: 2007 ident: 10.1016/j.abb.2023.109716_bib110 article-title: Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4273 – volume: 69 start-page: 4489 issue: 7 year: 1995 ident: 10.1016/j.abb.2023.109716_bib73 article-title: Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line publication-title: J. Virol. doi: 10.1128/jvi.69.7.4489-4494.1995 – volume: 18 start-page: 13 issue: 1 year: 2023 ident: 10.1016/j.abb.2023.109716_bib30 article-title: The complexity of human papilloma virus in cancers: a narrative review publication-title: Infect. Agents Cancer doi: 10.1186/s13027-023-00488-w – volume: 8 start-page: 1492 issue: 4 year: 2014 ident: 10.1016/j.abb.2023.109716_bib92 article-title: Reduced expression of autophagy markers correlates with high-risk human papillomavirus infection in human cervical squamous cell carcinoma publication-title: Oncol. Lett. doi: 10.3892/ol.2014.2417 – volume: 301 start-page: 1365 issue: 6 year: 2020 ident: 10.1016/j.abb.2023.109716_bib98 article-title: COX-2-PGE(2)-EPs in gynecological cancers publication-title: Arch. Gynecol. Obstet. doi: 10.1007/s00404-020-05559-6 – volume: 140 start-page: 3079 issue: 15 year: 2013 ident: 10.1016/j.abb.2023.109716_bib104 article-title: Cdks, cyclins and CKIs: roles beyond cell cycle regulation publication-title: Development doi: 10.1242/dev.091744 – volume: 9 issue: 9 year: 2017 ident: 10.1016/j.abb.2023.109716_bib31 article-title: Keratinocyte differentiation-dependent human papillomavirus gene regulation publication-title: Viruses doi: 10.3390/v9090245 – volume: 19 start-page: 167 issue: 2 year: 2021 ident: 10.1016/j.abb.2023.109716_bib108 article-title: Cellular functions of HPV16 E5 oncoprotein during oncogenic transformation publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-20-0491 – volume: 72 start-page: 26 issue: 1 year: 2018 ident: 10.1016/j.abb.2023.109716_bib5 article-title: Prevalence of specific types of human papiloma virus in cervical intraepithelial lesions and cervical cancer in Macedonian women publication-title: Med. Arch. doi: 10.5455/medarh.2018.72.26-30 – volume: 30 start-page: 753 issue: 5 year: 2009 ident: 10.1016/j.abb.2023.109716_bib115 article-title: Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein publication-title: Carcinogenesis doi: 10.1093/carcin/bgp066 – volume: 18 start-page: 233 issue: 2 year: 2007 ident: 10.1016/j.abb.2023.109716_bib121 article-title: Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis publication-title: Ann. Oncol. doi: 10.1093/annonc/mdl347 – volume: 13 start-page: 291 issue: 2 year: 2017 ident: 10.1016/j.abb.2023.109716_bib124 article-title: HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy publication-title: Hum. Vaccines Immunother. doi: 10.1080/21645515.2017.1264777 – volume: 12 start-page: 38 year: 2013 ident: 10.1016/j.abb.2023.109716_bib58 article-title: Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway publication-title: Mol. Cancer doi: 10.1186/1476-4598-12-38 – volume: 132 start-page: 27 issue: 1 year: 2008 ident: 10.1016/j.abb.2023.109716_bib91 article-title: Autophagy in the pathogenesis of disease publication-title: Cell doi: 10.1016/j.cell.2007.12.018 – volume: 6 start-page: 19 year: 2006 ident: 10.1016/j.abb.2023.109716_bib13 article-title: Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts publication-title: Cancer Cell Int. doi: 10.1186/1475-2867-6-19 – volume: 452–453 start-page: 223 year: 2014 ident: 10.1016/j.abb.2023.109716_bib61 article-title: Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation publication-title: Virology doi: 10.1016/j.virol.2014.01.013 – volume: 67 start-page: 4521 issue: 8 year: 1993 ident: 10.1016/j.abb.2023.109716_bib113 article-title: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes publication-title: J. Virol. doi: 10.1128/jvi.67.8.4521-4532.1993 – volume: 18 start-page: 807 issue: 6 year: 2012 ident: 10.1016/j.abb.2023.109716_bib112 article-title: Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer publication-title: J. Infect. Chemother. doi: 10.1007/s10156-012-0485-5 |
SSID | ssj0011462 |
Score | 2.4940002 |
SecondaryResourceType | review_article |
Snippet | For a considerable duration, cervical cancer has posed a significant risk to the well-being and survival of women. The emergence and progression of cervical... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 109716 |
SubjectTerms | adhesion apoptosis biophysics carcinogenesis carcinogenicity Cell apoptosis cell growth cell proliferation chemical structure E5 oncoprotein energy metabolism etiology genes Growth factors HPV16 oncogene proteins risk therapeutics uterine cervical neoplasms |
Title | Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis |
URI | https://dx.doi.org/10.1016/j.abb.2023.109716 https://www.ncbi.nlm.nih.gov/pubmed/37553047 https://www.proquest.com/docview/2848230055 https://www.proquest.com/docview/2887633901 |
Volume | 745 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSyQxEC5EkfWy-NjVWR9EWPaw0DrpPHr6OA4Oo6LsQRdvIekkSy9Ot-yMh7342011dwYEnYO3TqcCoVJUVVKPD-B732NTcsMSKkyacD-QST7AEKLhuXXcU2GxwPn6Rk7u-OW9uF-BUayFwbTKTve3Or3R1t2f046bp49liTW-fZYPsH1Ia7iwgp1nKOUnz4s0Dyy6TSNqHlLHyGaT46WNOUH88KaRI0Kev22b3vM9Gxs03oTPnfNIhu3-tmDFVduwM6zCxXn6n_wgTTpn806-Detn8evTKIK67cB42Mb8Z6SsyDRC45KpwwLgcjYltSeTX7-pJOeC1FVRN30cAm2BmENV_QdVYzn7Anfj89vRJOmgFJKCDeQ8CX6VY5aL3MgsOE1Wy9ywwlPrpJaUSs-tCUaMh4FhPng1PLPS5CazRgtLKfsKq1VduT0gWqS6YFlquffhLmm18GnwoRwNE1RntAf9yERVdH3GEe7iQcWEsr8q8F0h31XL9x78XCx5bJtsLCPm8WTUK0lRwQgsW3YcT1EFnmNYRFeufpqpYKAx2tgXYhkNdu7D96Ee7LYisNgpyxB6iWffPraxfdjAUZu3dgCr839P7jA4OnNz1EjyEawNL64mNy-0nfgs |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7yoCSX0ry3rygQegg4WVkPr4_bJcvmSQ5JyU1IlhRcunbobg699LdXY1sLgXYPvdnWCMRoPDPSPD6A477HpuSGJVSYNOF-IJN8gCFEw3PruKfCYoHzza2cPPDLR_G4AqNYC4NplZ3ub3V6o627L2cdN8-eyxJrfPssH2D7kNZwrcI6D78vwhic_l7keWDVbRph85A8hjabJC9tzCkCiDedHBHz_O_G6V_OZ2OExu_gbec9kmG7wC1YcdU27AyrcHKe_iJfSJPP2VyUb8Obr_FpYxRR3XZgPGyD_jNSVmQasXHJ1GEFcDmbktqTyd03Ksm5IHVV1E0jh0BbIOhQVT-hbixnu_AwPr8fTZIOSyEp2EDOk-BYOWa5yI3MgtdktcwNKzy1TmpJqfTcmmDFeHgxzAe3hmdWmtxk1mhhKWV7sFbVlTsAokWqC5allnsfDpNWC58GJ8rRMEB1RnvQj0xURddoHPEufqiYUfZdBb4r5Ltq-d6Dk8WU57bLxjJiHndGvRIVFazAsmlHcRdV4DnGRXTl6peZChYaw419IZbRYOs-vCDqwX4rAouVsgyxl3j2_v8Wdggbk_uba3V9cXv1ATZxpE1i-whr858v7lPweubmcyPVfwBdp_m6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+in+molecular+mechanism+of+HPV16+E5+oncoprotein+carcinogenesis&rft.jtitle=Archives+of+biochemistry+and+biophysics&rft.au=Chen%2C+Biqing&rft.au=Zhao%2C+Liping&rft.au=Yang%2C+Rulin&rft.au=Xu%2C+Tianmin&rft.date=2023-09-01&rft.eissn=1096-0384&rft.volume=745&rft.spage=109716&rft_id=info:doi/10.1016%2Fj.abb.2023.109716&rft_id=info%3Apmid%2F37553047&rft.externalDocID=37553047 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9861&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9861&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9861&client=summon |